HomeProductsBuilding BlocksHeterocyclic ScaffoldsPyrrolidinesVosoritide
Chemical structure of CAS 1480724-61-5

Vosoritide

In Stock•Starting at $153 for 10 mg•Purity ≥ 98%
CAS No.1480724-61-5
MDL No.N/A
MFC176H290N56O51S3
MW4103.00
InChI KeyIGYWDDBBJPSOTG-WBAGYEQSSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
10 mg98% acetate$153In Stock
25 mg98% acetate$288In Stock
50 mg98% acetate$486In Stock
100 mg98% acetate$824In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1480724-61-5
Product NameVosoritide
Heavy Atom Count286Rotatable Bond Count110
Atom Stereo Count32Bond Stereo Count0
HBA61HBD61
TPSA1739.730 ŲCharge0
Exact Mass4100.09826Complexity10184.86
pKa4.610XLogP-20.989

Related Articles

Studies related to this compound and its mechanism of action

C-Type Natriuretic Peptide Analogue Therapy in Children with Achondroplasia.

The New England journal of medicine • Vol. 381, Issue 1 • 2019
PMID: 31269546DOI: 10.1056/NEJMoa1813446

Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism.

The Journal of pharmacology and experimental therapeutics • Vol. 353, Issue 1 • 2015
PMID: 25650377DOI: 10.1124/jpet.114.218560

Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.

American journal of human genetics • Vol. 91, Issue 6 • 2012
PMID: 23200862PMC: PMC3516592DOI: 10.1016/j.ajhg.2012.10.014

Documentation

Similar Products